medroxyprogesterone acetate has been researched along with Blood Pressure, High in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 13 (56.52) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Aragaki, AK; Gass, M; Jiang, X; Manson, JE; Martin, LW; Nudy, M; Pan, K; Robbins, JA; Schnatz, PF; Shadyab, AH; Stefanick, ML; Valdiviezo, C; Wild, RA | 1 |
| Aragaki, AK; Bassuk, SS; Kaunitz, A; Manson, JE; Rossouw, J; Shimbo, D; Stefanick, ML; Swica, Y; Warren, MP; Womack, CR | 1 |
| Curb, JD; Manson, JE; Martin, LW; Phillips, L; Stefanick, M; Trevisan, M; Wild, RA; Wu, C | 1 |
| Irish, A; Kong, WY; Leedman, P | 1 |
| Emans, SJ; Pitts, SA | 1 |
| Colenda, CC; Espeland, MA; Fillit, H; Johnson, KC; Manson, JE; Margolis, KL; Masaki, KH; Mouton, CP; Prineas, R; Robinson, JG; Wassertheil-Smoller, S | 1 |
| Blanchette, PL; Cochrane, B; Ko, MG; Limacher, M; Ockene, JK; Ren, H; Robinson, JG; Wallace, R; Wassertheil-Smoller, S | 1 |
| Hitchcock, CL; Kalyan, S; Prior, JC; Pudek, M; Sirrs, S | 1 |
| Bryan, NR; Gaussoin, SA; Kerwin, D; Kuller, LH; Limacher, M; Margolis, KL; Robinson, JG; Wassertheil-Smoller, S; Williamson, J | 1 |
| Weisberg, E | 1 |
| Ahn, JY; Choi, IS; Jin, DK; Kim, DS; Kim, HS; Koh, KK; Shin, EK; Shin, MS; Son, JW; Yoon, BK | 1 |
| Luyando, H; Rustrian, A | 1 |
| Fukumura, Y; Ichikawa, S; Kanda, T; Kotajima, N; Kurabayashi, M; Murakami, M; Sumino, H; Tamama, K | 1 |
| Ichikawa, S; Kanda, T; Kumakura, H; Kurabayashi, M; Sakamaki, T; Sumino, H; Takayama, Y | 1 |
| Barrett-Connor, E; Bibbins-Domingo, K; Grady, D; Hulley, SB; Lin, F; Shlipak, MG; Vittinghoff, E | 1 |
| Artini, PG; Battaglia, C; de Aloysio, D; de Iaco, P; Mancini, F; Persico, N; Volpe, A | 1 |
| Bakry, S; Fadiel, A; Mahmoud, MS; Merhi, ZO; Naftolin, F; Scalise, TJ | 1 |
| Modena, MG; Molinari, R; Muia, N; Origliani, G; Rombolà, O; Rossi, R | 1 |
| Acs, N; Miklós, Z; Monos, E; Nádasy, GL; Székács, B; Tökés, AM; Vajó, Z; Várbíró, S | 1 |
| Harvey, PJ; Molloy, D; Upton, J; Wing, LM | 1 |
| Campbell, L; Hayward, CS; Kelly, RP; Samaras, K | 1 |
| Affinito, P; Bonifacio, M; Fontana, D; Izzo, R; Nappi, C; Palomba, S; Trimarco, B | 1 |
| Hurlet, A; Hyjazi, Y; Maes, E; Masure, R; Vekemans, M | 1 |
2 review(s) available for medroxyprogesterone acetate and Blood Pressure, High
| Article | Year |
|---|---|
Controversies in contraception.
Topics: Adolescent; Contraception; Contraceptive Agents, Female; Female; Humans; Hypertension; Medroxyprogesterone Acetate; Migraine Disorders; Obesity; Osteoporosis; Venous Thromboembolism; Weight Gain | 2008 |
Depot-medroxyprogesterone acetate: an update.
Topics: Abnormalities, Drug-Induced; Anemia, Sickle Cell; Animals; Arachnoiditis; Body Weight; Bone Density; Contraceptive Agents, Female; Female; Humans; Hypertension; Lactation; Lipoproteins; Liver; Medroxyprogesterone Acetate; Neoplasms | 2008 |
11 trial(s) available for medroxyprogesterone acetate and Blood Pressure, High
| Article | Year |
|---|---|
The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hypertension; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Women's Health | 2023 |
Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials.
Topics: Aged; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hypertension; Incidence; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; United States | 2018 |
Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
Topics: Aged; Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hypertension; Hysterectomy; Medroxyprogesterone Acetate; Metabolic Syndrome; Middle Aged; Odds Ratio; Placebos; Postmenopause; Risk Factors; Women's Health | 2013 |
A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory Study.
Topics: Aged; Alzheimer Disease; Blood Pressure; Calcium; Cognition Disorders; Coronary Disease; Drug Combinations; Estrogens, Conjugated (USP); Feeding Behavior; Female; Humans; Hypertension; Medroxyprogesterone Acetate; Mental Status Schedule; Middle Aged; Postmenopause; Proportional Hazards Models; Prospective Studies; Psychometrics; Risk Assessment; Risk Factors; Statistics as Topic; Vitamin D | 2008 |
Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
Topics: Adipose Tissue; Adult; Body Mass Index; Cardiovascular Diseases; Double-Blind Method; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hypertension; Hysterectomy; Inflammation Mediators; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Metabolic Syndrome; Middle Aged; Ovariectomy; Progestins; Risk Factors; Serum Albumin | 2010 |
Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women.
Topics: Animals; Biomarkers; Brachial Artery; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Horses; Humans; Hypertension; Inflammation; Lipids; Medroxyprogesterone Acetate; Middle Aged; Obesity; Postmenopause; Progesterone; Progesterone Congeners; Regional Blood Flow; Vasomotor System | 2002 |
Hormone replacement therapy causes a decrease in hepatocyte growth factor in hypertensive women.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Estrogen Replacement Therapy; Estrogens; Female; Hepatocyte Growth Factor; Humans; Hypertension; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies | 2003 |
Effects of hormone replacement therapy on office and ambulatory blood pressure in Japanese hypertensive postmenopausal women.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hypertension; Medroxyprogesterone Acetate; Middle Aged; Physicians' Offices | 2003 |
Dose response effect of conjugated equine oestrogen on blood pressure in postmenopausal women with hypertension.
Topics: Aldosterone; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Cross-Over Studies; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Hypertension; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Renin; Sex Hormone-Binding Globulin; Systole | 2000 |
Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women.
Topics: Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Arteries; Cross-Over Studies; Diabetes Mellitus, Type 2; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hypertension; Manometry; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Prospective Studies | 2001 |
Effects of hormonal replacement therapy in postmenopausal hypertensive patients.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cholesterol; Circadian Rhythm; Diuretics; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypertension; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Triglycerides | 2001 |
10 other study(ies) available for medroxyprogesterone acetate and Blood Pressure, High
| Article | Year |
|---|---|
A case of iatrogenic Cushing syndrome and apparent mineralocorticoid excess presenting with accelerated hypertension and proteinuria.
Topics: Antineoplastic Agents, Hormonal; Cushing Syndrome; Female; Humans; Hypertension; Iatrogenic Disease; Medroxyprogesterone Acetate; Middle Aged; Mineralocorticoid Excess Syndrome, Apparent; Proteinuria; Treatment Outcome | 2014 |
Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
Topics: Aged; Cardiovascular Diseases; Chest Pain; Contraceptive Agents, Female; Diabetes Mellitus; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Hospitalization; Humans; Hypertension; Medroxyprogesterone Acetate; Middle Aged; Myocardial Revascularization; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk | 2008 |
Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial.
Topics: Age Factors; Aged; Antihypertensive Agents; Blood Pressure; Brain; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Hypertension; Hypertensive Encephalopathy; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Memory; Mental Status Schedule; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; United States | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
[Clinical investigation of medroxyprogesterone acetate and estradiol cypionate in contraceptive injection administered monthly].
Topics: Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endocrine System; Endometrium; Estradiol; Estrogens; Family Planning Services; Genitalia; Genitalia, Female; Hormones; Hypertension; Injections; Medroxyprogesterone Acetate; Physiology; Research; Urogenital System; Uterus; Vascular Diseases | 1975 |
Predictors of heart failure among women with coronary disease.
Topics: Aged; Atrial Fibrillation; Black or African American; Bundle-Branch Block; Cohort Studies; Comorbidity; Coronary Disease; Diabetes Mellitus; Estrogens, Conjugated (USP); Follow-Up Studies; Heart Failure; Hormone Replacement Therapy; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Medroxyprogesterone Acetate; Middle Aged; Obesity; Postmenopause; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors | 2004 |
Transdermal HRT and Doppler findings in normotensive and hypertensive postmenopausal patients.
Topics: Administration, Cutaneous; Analysis of Variance; Arteries; Blood Viscosity; Carotid Artery, Internal; Case-Control Studies; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypertension; Linear Models; Medroxyprogesterone Acetate; Middle Aged; Ophthalmic Artery; Postmenopause; Regional Blood Flow; Thromboxane B2; Ultrasonography, Doppler; Urinary Bladder; Uterus; Vascular Resistance | 2005 |
Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension.
Topics: Antihypertensive Agents; Cardiovascular Diseases; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypertension; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Risk Factors; Time Factors | 1998 |
Effect of ovariectomy and hormone replacement therapy on small artery biomechanics in angiotensin-induced hypertension in rats.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Elasticity; Estradiol; Female; Hormone Replacement Therapy; Hypertension; Medroxyprogesterone Acetate; Menopause; Ovariectomy; Progesterone Congeners; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Weight Gain | 2000 |
[Depot medroxyprogesterone acetate: clinical and metabolic effects (lipids, glucose, hemostasis)].
Topics: Adolescent; Adult; Animals; Blood Glucose; Body Weight; Contraceptive Agents, Female; Delayed-Action Preparations; Dogs; Female; Hemostasis; Humans; Hypertension; Injections, Intramuscular; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Retrospective Studies | 1985 |